发明名称 |
ALGORITHM FOR PREDICTION OF BENEFIT FROM ADDITION OF TAXANE TO STANDARD CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER |
摘要 |
<p>The invention relates to a method or predicting an outcome of cancer in a patient suffering from cancer, said method comprising : (a) determining in a biological sample from said patient the expression level of at least one marker gene selected from AKR1C3, MAP4, SPP1, CXCL9, PTGER3, and VEGFC; (b) comparing said expression level to a reference pattern of expression, wherein an increased expression of said at least one marker gene is indicative of said patient having a benefit from microtubule stabilizing agent-based cytotoxic chemotherapy.</p> |
申请公布号 |
EP2553119(A1) |
申请公布日期 |
2013.02.06 |
申请号 |
EP20110711550 |
申请日期 |
2011.03.30 |
申请人 |
WIRTZ, RALPH |
发明人 |
FOUNTZILAS, GEORGE;GEHRMANN, MATHIAS;KRONENWETT, RALF;STROPP, UDO;WEBER, KARSTEN;WIRTZ, RALPH |
分类号 |
C12Q1/68;G01N33/574 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|